INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,706 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
DS
Denbaars StevenDirector
ALMUAeluma, Inc.
Open-market sale
SELL$173K
12.5K sh
Aug 27, 2026Aug 28, 2026
Page 434 of 1693
← PrevNext →
traded Aug 27, 2026
+1d
SEC Form 4

Evidence

20
VC
Voss Capital, LP10% Owner
FLYWFlywire Corp
Open-market sale
SELL$485K
25.5K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

20
HP
Harden Sarah PatriciaDirector
MGNIMAGNITE, INC.
Open-market sale · 10b5-1 plan
SELL$712K
30.6K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

19
SS
Spittle SteveChief Commercial Officer
MIDDMIDDLEBY Corp
Derivative conversion
C—
1,823 sh
Jul 20, 2026Aug 28, 2026
traded Jul 20, 2026
+39dSEC Form 4

Evidence

19
CC
Cerwin Brittany CChief Accounting Officer
MIDDMIDDLEBY Corp
Derivative conversion
C—
877 sh
Jul 20, 2026Aug 28, 2026
traded Jul 20, 2026
+39dSEC Form 4

Evidence

19
PK
Pool III James KChief Technology and*
MIDDMIDDLEBY Corp
Derivative conversion
C—
1,823 sh
Jul 20, 2026Aug 28, 2026
traded Jul 20, 2026
+39dSEC Form 4

Evidence

19
SM
Sterling Michelle MDirector
APPSDigital Turbine, Inc.
Grant or award
A—
19.0K sh
Aug 25, 2026Aug 28, 2026
traded Aug 25, 2026
+3dSEC Form 4

Evidence

18
SS
Saxonov SergeDirector, Chief Executive Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL$221K
3,500 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

17
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Derivative conversion
C—
10.0K sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

17
SS
Suarez Gonzalez SusanaEX. VP & CHIEF HUMAN RESOURCES
AMCRAmcor plc
Option exercise
M—
4,682 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

17
HR
Hamady Robert RamseyChief Financial Officer
SMRNUSCALE POWER Corp
Option exercise
M—
76.9K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

17
FJ
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$2.10M
6,517 sh
Aug 10, 2026Aug 28, 2026
traded Aug 10, 2026
+18dSEC Form 4

Evidence

17
HJ
Hyman JonathanChief Technology Officer
BRZEBraze, Inc.
Open-market sale · 10b5-1 plan
SELL$1.05M
32.7K sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

15
SS
Saxonov SergeDirector, Chief Executive Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
492 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

15
MJ
McCarthy Daniel JosephPRESIDENT
EVHEvolent Health, Inc.
Open-market sale · 10b5-1 plan
SELL$329K
65.9K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

14
VC
Voss Capital, LP10% Owner
FLYWFlywire Corp
Open-market sale
SELL$11K
555 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

14
VC
Voss Capital, LP10% Owner
FLYWFlywire Corp
Open-market sale
SELL$38K
1,996 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

14
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$227K
52.0K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

14
HJ
Hyman JonathanChief Technology Officer
BRZEBraze, Inc.
Open-market sale · 10b5-1 plan
SELL$309K
9,320 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

13
SS
Suarez Gonzalez SusanaEX. VP & CHIEF HUMAN RESOURCES
AMCRAmcor plc
Tax withholding
F—
1,654 sh
Aug 28, 2026Aug 28, 2026
traded Aug 28, 2026
+0dSEC Form 4

Evidence

13
SS
Suarez Gonzalez SusanaEX. VP & CHIEF HUMAN RESOURCES
AMCRAmcor plc
Option exercise
M—
4,554 sh
Aug 28, 2026Aug 28, 2026
traded Aug 28, 2026
+0dSEC Form 4

Evidence

13
WI
Wilson IanEXECUTIVE VICE PRESIDENT
AMCRAmcor plc
Option exercise
M—
5,616 sh
Aug 28, 2026Aug 28, 2026
traded Aug 28, 2026
+0dSEC Form 4

Evidence

13
WH
Warrington Kenneth Howard JrDirector
BSEMBioStem Technologies, Inc.
Option exercise
M—
5,094 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

13
GL
Grindstaff LyndaDirector
OFGOFG BANCORP
Grant or award
A—
50 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

13
SM
Sorrells Julie MarieV.P. & CORPORATE CONTROLLER
AMCRAmcor plc
Option exercise
M—
769 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

13
SM
Sorrells Julie MarieV.P. & CORPORATE CONTROLLER
AMCRAmcor plc
Option exercise
M—
1,047 sh
Aug 28, 2026Aug 28, 2026
traded Aug 28, 2026
+0dSEC Form 4

Evidence

13
AA
Asmerom AmineChief Accounting Officer
CHYMChime Financial, Inc.
Grant or award
A—
92.4K sh
Aug 28, 2026Aug 28, 2026
traded Aug 28, 2026
+0dSEC Form 4

Evidence

13
SS
Suarez Gonzalez SusanaEX. VP & CHIEF HUMAN RESOURCES
AMCRAmcor plc
Tax withholding
F—
2,075 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

12
EM
Evinger David M.Director, President, Chief Risk Officer
CBNACHAIN BRIDGE BANCORP INC
Gift
G—
340 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

12
BE
Bunting EricDirector
QSEPQS Energy, Inc.
Other acquisition or disposition
J$15K
150.0K sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

12
EM
Evinger David M.Director, President, Chief Risk Officer
CBNACHAIN BRIDGE BANCORP INC
Gift
G—
340 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

11
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
52.0K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

10
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$150K
25.0K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

10
HM
Hanson Scott McLeanDirector, Chief Technology Officer
AMBQAmbiq Micro, Inc.
Option exercise
M—
27.5K sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

10
HM
Hanson Scott McLeanDirector, Chief Technology Officer
AMBQAmbiq Micro, Inc.
Option exercise
M—
10.0K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

10
HM
Hanson Scott McLeanDirector, Chief Technology Officer
AMBQAmbiq Micro, Inc.
Option exercise
M—
27.5K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
HT
Hagale James TysonPresident - Leggett & Platt
SGISOMNIGROUP INTERNATIONAL INC.
Grant or award
A—
8,978 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
UJ
Ungrodt JodiDirector
BSEMBioStem Technologies, Inc.
Option exercise
M—
5,647 sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC Form 4

Evidence

9
RC
Redett John C.Co-President
CGCarlyle Group Inc.
Grant or award
A—
8,302 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC Form 4

Evidence

9
VC
Volker ChristopherChief Financial Officer
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Grant or award
A—
35.0K sh
Aug 28, 2026Aug 28, 2026
traded Aug 28, 2026
+0dSEC Form 4

Evidence